Stockscreener 앱 받기
25.34
2.91%
-0.76
시간 외 거래:
21.94
-3.40
-13.42%
Stoke Therapeutics Inc 주식(STOK)의 최신 뉴스
Earnings call transcript: Stoke Therapeutics Q3 2025 shows revenue beat - Investing.com
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Stoke Therapeutics' Revenue Beats Expectations But Losses Widen - Finimize
Stoke Therapeutics Inc (STOK) Q3 2025 Earnings: Revenue Surges t - GuruFocus
Earnings Flash (STOK) Stoke Therapeutics, Inc. Reports Q3 Revenue $10.6M, vs. FactSet Est of $6.2M - MarketScreener
Stoke Therapeutics : Q3 2025 Webcast Slides - MarketScreener
Stoke Therapeutics Q3 revenue beats estimates on Acadia, Biogen agreements - TradingView
Stoke Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - FinancialContent
JPMorgan Chase & Co. Raises Stoke Therapeutics (NASDAQ:STOK) Price Target to $25.00 - MarketBeat
What technical models suggest about Stoke Therapeutics Inc.’s comebackJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Can Stoke Therapeutics Inc. stock resist sector downturnsMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Using portfolio simulators with Stoke Therapeutics Inc. includedJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
JP Morgan Maintains Stoke Therapeutics (STOK) Neutral Recommendation - Nasdaq
Stoke Therapeutics (STOK): JP Morgan Raises Price Target, Mainta - GuruFocus
Live market analysis of Stoke Therapeutics Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Why Stoke Therapeutics Inc. stock attracts high net worth investorsQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Can Stoke Therapeutics Inc. stock sustain institutional interestMarket Activity Summary & Daily Momentum Trading Reports - newser.com
What insider trading reveals about Stoke Therapeutics Inc. stockGold Moves & High Accuracy Trade Alerts - newser.com
Is Stoke Therapeutics Inc. stock a good choice for value investorsQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
Does Stoke Therapeutics Inc. show high probability of reboundWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com
Will Stoke Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat
Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView
Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Stoke Therapeutics, Inc. (STOK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Total debt per share of Stoke Therapeutics, Inc. – BER:0GT - TradingView
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates - Yahoo Finance
Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - Nasdaq
Stoke Therapeutics (STOK) Projected to Post Earnings on Tuesday - MarketBeat
1.45%
0.86%
자본화:
|
볼륨(24시간):